Insights

Clinical Potential Alterity Therapeutics is a clinical stage biotech focused on neurodegenerative diseases with ATH434, an oral agent targeting alpha-synuclein aggregation and iron balance. This presents an opportunity to engage with investors and healthcare partners interested in Parkinsonian disorders and MSA, highlighting potential avenues for co-development discussions and strategic partnerships on later-stage trials or companion diagnostics.

Strategic Partners The company operates with a broad drug discovery platform and has offices in Melbourne and San Francisco, suggesting potential for cross-border collaboration. Outreach to large pharma and specialty biotech firms seeking early-stage neuroscience assets could yield licensing, collaboration, or sponsored research deals around ATH434 and related compounds.

Investor & Events Regular conference participation and investor-focused communications indicate ongoing fundraising and visibility needs. This creates sales opportunities to connect with CROs, investors, and service providers that support clinical development, data generation, and regulatory submissions, as well as potential sponsorship or advisory partnerships.

Clinical Signals Positive clinical signals for ATH434 in Multiple System Atrophy, highlighted at the American Academy of Neurology and in MuSyCA scale discussions, provide a compelling narrative for outreach to contract research organizations, patient advocacy groups, and clinical researchers who can contribute to trial recruitment, investigator-initiated studies, or consulting engagements.

Financial & Growth With modest revenue and existing funding, Alterity may seek strategic collaborations, milestone-based deals, or consulting services to de-risk and accelerate development. Opportunities exist to propose services around clinical operations support, pharmacovigilance, and regulatory strategy to extend runway and advance ATH434's development plan.

Similar companies to Alterity Therapeutics

Alterity Therapeutics Tech Stack

Alterity Therapeutics uses 8 technology products and services including Open Graph, WordPress, Shopify, and more. Explore Alterity Therapeutics's tech stack below.

  • Open Graph
    Content Management System
  • Content Management System
  • E-commerce
  • Lightbox
    Javascript Libraries
  • X-Content-Type-Options
    Web & Portal Technology
  • LiteSpeed
    Web Servers
  • FitVids.js
    Web Tools And Plugins

Media & News

Alterity Therapeutics's Email Address Formats

Alterity Therapeutics uses at least 2 email formats:
Alterity Therapeutics Email FormatsExamplePercentage
First.Last@alteritytherapeutics.comJohn.Doe@alteritytherapeutics.com
65%
FLast@alteritytherapeutics.comJDoe@alteritytherapeutics.com
35%

Frequently Asked Questions

What is Alterity Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Alterity Therapeutics is a publicly traded company; the company's stock symbol is ATHE.

What is Alterity Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Alterity Therapeutics's official website is alteritytherapeutics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Alterity Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Alterity Therapeutics's annual revenue is estimated to be $1M - $10M.

What is Alterity Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Alterity Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Alterity Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Alterity Therapeutics has approximately 12 employees across 2 continents, including Oceania and North America. Key team members include Chief Executive Officer: D. S., Senior Director, Cmc: E. G. and Director Clinical Operations: C. L. Explore Alterity Therapeutics's employee directory with LeadIQ.

What industry does Alterity Therapeutics belong to?

Minus sign iconPlus sign icon
Alterity Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Alterity Therapeutics use?

Minus sign iconPlus sign icon
Alterity Therapeutics's tech stack includes Open Graph, WordPress, Shopify, Microsoft 365, Lightbox, X-Content-Type-Options, LiteSpeed and FitVids.js.

What is Alterity Therapeutics's email format?

Minus sign iconPlus sign icon
Alterity Therapeutics's email format typically follows the pattern of First.Last@alteritytherapeutics.com. Find more Alterity Therapeutics email formats with LeadIQ.

How much funding has Alterity Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Alterity Therapeutics has raised $45M in funding. The last funding round occurred on Sep 08, 2025 for $13M.
Alterity Therapeutics logo

Alterity Therapeutics

Pharmaceutical ManufacturingVictoria, Australia11-50 Employees

Alterity Therapeutics is a clinical-stage biotechnology company aiming to modify the course of neurodegenerative diseases and improve patient quality of life. Its lead candidate, ATH434, is an oral agent intended to inhibit the aggregation of pathological proteins implicated in neurodegeneration, with preclinical data suggesting it reduces α-synuclein pathology and helps restore normal brain iron balance. The program targets Parkinsonian disorders, including Multiple System Atrophy, and the company maintains offices in Melbourne, Australia and San Francisco, USA.

In addition to ATH434, Alterity operates a broader drug-discovery platform that generates patentable compounds to intervene in disease processes. A recent development noted in 2026 involves positive regulatory feedback from an FDA Type C meeting regarding the planned Phase 3 program for ATH434 in MSA.

Section iconCompany Overview

Stock Symbol
ATHE
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
11-50

Section iconFunding & Financials

  • $45M

    Alterity Therapeutics has raised a total of $45M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2025 in the amount of $13M as a Post IPO Equity.

  • $1M - $10M

    Alterity Therapeutics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.